Compounds > capecitabine
Page last updated: 2024-08-24

capecitabine and Hyperammonemia

capecitabine has been researched along with Hyperammonemia in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (57.14)24.3611
2020's3 (42.86)2.80

Authors

AuthorsStudies
Agatsuma, N; Imamaki, H; Nishikawa, Y; Oguro, F; Oura, M1
Campana, D; Di Federico, A; Lenzi, B; Nobili, E; Nuvola, G; Sisi, M1
Armesto González, EM; Cano Calderero, FX; Cerrella Cano, C; Junquera Alonso, E; Seoane Blanco, L; Terroba Alonso, M1
Fang, W; Fu, Y; Wei, J1
Chu, G; Salzman, J1
Hirakawa, H; Kanno, N; Kikuchi, Y; Kuroki, M; Matsumura, Y; Miura, A; Nakano, E1
Advani, PP; Fakih, MG1

Other Studies

7 other study(ies) available for capecitabine and Hyperammonemia

ArticleYear
Fluoropyrimidine usage in cases with hyperammonemia: real-world data study using the Japanese Adverse Drug Event Report (JADER) database.
    Cancer chemotherapy and pharmacology, 2023, Volume: 92, Issue:1

    Topics: Antimetabolites; Antineoplastic Agents; Capecitabine; Drug-Related Side Effects and Adverse Reactions; Fluorouracil; Humans; Hyperammonemia; Japan; Tegafur

2023
Hyperammonemic encephalopathy during XELOX regimen. Is it capecitabine or oxaliplatin responsible?
    Anti-cancer drugs, 2020, Volume: 31, Issue:10

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Capecitabine; Electroencephalography; Humans; Hyperammonemia; Lactulose; Lung Neoplasms; Male; Oxaliplatin; Oxaloacetates

2020
Capecitabine-induced hyperammonemic encephalopathy.
    Revista espanola de enfermedades digestivas, 2022, Volume: 114, Issue:1

    Topics: Adenocarcinoma; Aged; Ammonia; Brain Diseases; Capecitabine; Humans; Hyperammonemia; Male; Pancreatic Neoplasms

2022
A Case of Capecitabine-induced Hyperammonemia in a Patient with Colon Cancer.
    Current drug safety, 2018, Volume: 13, Issue:1

    Topics: Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Female; Humans; Hyperammonemia; Middle Aged

2018
Hyperammonemia after capecitabine associated with occult impairment of the urea cycle.
    Cancer medicine, 2019, Volume: 8, Issue:5

    Topics: Aged; Antimetabolites, Antineoplastic; Capecitabine; Female; Humans; Hyperammonemia; Stomach Neoplasms; Urea

2019
[A case of metastatic colorectal cancer with hyperammonemic encephalopathy induced by 5-FU in a patient continuously treated with XELOX therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:13

    Topics: Amino Acids, Branched-Chain; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases, Metabolic; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Hyperammonemia; Liver Neoplasms; Male; Oxaloacetates; Rectal Neoplasms

2013
5-FU-induced hyperammonemic encephalopathy in a case of metastatic rectal adenocarcinoid successfully rechallenged with the fluoropyrimidine analog, capecitabine.
    Anticancer research, 2011, Volume: 31, Issue:1

    Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Brain Diseases; Capecitabine; Deoxycytidine; Female; Fluorouracil; Humans; Hyperammonemia; Liver Neoplasms; Rectal Neoplasms; Treatment Outcome

2011